Alison Long

Alison Long is an experienced medical professional currently serving as Chief Medical Officer at Flightpath Biosciences, Inc. and Clinical Lead at ENIGMA BIOMEDICAL GROUP, while also acting as Principal Consultant for Long Biopharma Consulting, LLC. Long has held significant roles in the biotechnology and pharmaceutical sectors, including former positions as Chief Medical Officer at Kaleido Biosciences and Interim Chief Medical Officer at Freeline. Prior experience includes leadership roles in clinical development and research at companies such as Spark Therapeutics, uniQure, Aegerion Pharmaceuticals, Biogen, and Galderma. Alison Long holds a Ph.D. from George Mason University and an MD from the University of the Witwatersrand.